Exelixis Inc. Common Stock vs MaxLinear Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $59.43 (market cap $14.48B), while MaxLinear Inc. Common Stock trades at $96.43 (market cap $9.74B). The key difference: Exelixis Inc. Common Stock is the larger of the two by market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, MaxLinear Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and MaxLinear Inc. Common Stock for 0 Days on average.
| EXEL | MXL | |
|---|---|---|
Market Cap | $14.48B | $9.74B |
Volume | 2,374,774 | 2,786,741 |
Sector | Health | Technology |
52-Week High | $59.13 | $128.03 |
52-Week Low | $34.54 | $13.05 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.81B | $9.83B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →